By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Ontario Genomics Institute has invested C$100,000 (US$101,000) in Toronto-based molecular diagnostics developer Rna Diagnostics to support further development of the company's lead test for chemotherapy management.

OGI provided the funding to Rna Diagnostics, which has its research lab in Sudbury, Ontario and uses technology developed at Sudbury's Laurentian University, through its Pre-Commercialization Business Development Fund.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.